Human Osteoprotegerin (OPG) PharmaGenie ELISA Kit (SBRS0952)

Osteoprotegerin (OPG) is a soluble member of the tumor necrosis factor receptor superfamily that acts as a decoy receptor for RANKL, regulating bone remodeling by suppressing osteoclast differentiation and activation. This PharmaGenie ELISA Kit from Assay Genie enables quantitative measurement of human OPG in conditioned cell culture media, citrated plasma, or serum specimens, supporting research into osteoporosis, rheumatoid arthritis, periodontal disease, vascular calcification, and tumor-associated bone loss. The kit is intended for research use only and provides all reagents needed for a 96-assay microplate format, including pre-coated plate strips, biotinylated detection antibody, recombinant standards, and streptavidin-HRP conjugate. Researchers investigating the RANK/RANKL/OPG signaling axis in metabolic bone disorders, inflammatory joint disease, or oncology can use the kit to monitor circulating OPG as a biomarker of osteoclast activity and bone resorption. Reconstituted components should be stored refrigerated between uses and protected from light to preserve antibody and conjugate activity, with a standard curve generated on each plate to quantify endogenous OPG in experimental samples.